| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Turbine We are building the world’s first first predictive simulation of patient biology. Truly meaningful medicine comes from breakthroughs?in deeply understanding patient biology. We are building the world’s first first predictive simulation of patient biology. We will empower the biopharma industry by informing the right experiments that identify and validate disease driving hidden effects. Drug Discovery, Biotechnology, Artificial Intelligence, in silico, Cell Biology, Simulated Experiments, Bioinformatics, and Pharmaceuticals Type: | 2 | 0 | 2 | 90 |
 | Triple Ring Technologies A trusted partner in bringing technology to life. Triple Ring Technologies is a co-development company headquartered in Silicon Valley, with offices in Boston, Toronto, and Copenhagen. We partner with clients in medtech, life sciences, and sustainability & the environment to create new technologies, launch innovative projects, and start new ventures. Our capabilities span early R&D, product development, manufacturing, regulatory approval, market access, strategic investment, and incubation. For more information, please visit www.tripleringtech.com. For inquiries, please email info@tripleringtech.com. Advanced Research & Development - applied to commercial problems, Innovation Programs, Medical Device Design, Prototyping, Modeling, Validation, Product Development / Design, Grant Funded … Type: | 3 | 0 | 3 | 102 |
 | BeBeez Italia [Automatic translation follows] The first publisher specializing in news and services on private investments in venture and debt capital EdiBeez is the publisher of BeBeez.it and CrowdfundingBuzz.it BeBeez is an online newspaper registered with the Court of Milan (Authorization no. 102 of 3 April 2013), born in the spring of 2013 from an idea by Stefania Peveraro (head of service of MF Milano Finanza) and Anna Gervasoni (general director of the Italian Association of Private Equity and Venture Capital, AIFI). Crowdfunding Buzz is a magazine dedicated to collecting news and information relating to all forms of crowdfunding. Born in December … | 35 | 0 | 35 | 9 |
 | Innogest Capital Investors in companies that make the difference, partner of entrepreneurial visionaries We are investors in companies that make the difference. We trust in great entrepreneurs, we partner with hard-working visionaries. Innogest is a Venture Capital firm focused on seed and early stage ventures, with more than € 200 milion of capital under management. We have over 100 years of cumulative professional experience in the digital and the healthcare fields. Innogest invests in high potential companies through a direct share in their equity and pays special attention to market potential and size. Innogest leverages its extensive network of contacts, working alongside … Tags: H2020 Type: | 4 | 0 | 1 | 16 |
 |  Cellomatics Biosciences Ltd Our expertise, Your discovery Cellomatics Biosciences Ltd. (www.cellomaticsbio.com) is a laboratory-based Contract Research Organisation (CRO) specialised in Oncology/Immuno-Oncology, Immunology/Inflammation and Respiratory therapeutic areas. Based at Colwick Quays Business Park, Nottingham UK, our experienced scientific team offers bespoke and innovative preclinical in vitro bioassay services to support our client’s drug development programmes. We work with diverse group of global clients including early start-ups, virtual/small to medium sized Biotechnology and Pharmaceutical companies. Multiplex Immunoassay, Target and biomarker validation, In vitro functional assays, Molecular Biology, Receptor binding, Toxicity testing, Immuno-Oncology, Oncology, Immunology, Inflammation, and Respiratory Type: | 1 | 0 | 0 | 20 |
 | Form the Future CIC We help young people find their route through education into employment, and provide employers access to future talent We connect young people to a world of career possibilities, inspire them to dream big and empower them to fulfil their potential. We want to equip young people with the experience and skills they will need to succeed in their career of choice, and enable businesses to recruit skilled workers locally. We bridge the gap between these two worlds and help them work together and achieve more. We deliver the skills service for the Greater Cambridge Partnership, linking schools and businesses to … Type: | 10 | 0 | 8 | 37 |
 | Parkinson's UK We’ll find a cure. Together. Powered by people. Funded by you. Improving life for everyone affected by Parkinson’s. Your mum, colleague or friend. Anyone can get Parkinson’s, young or old. Every hour, two more people are diagnosed. Unlocking new treatments means delving into the causes of Parkinson’s. That’s why we fund the Parkinson's UK Brain Bank – the world's only brain bank dedicated to Parkinson's research. Over 10,000 people have donated their brains to help scientists around the world to unravel the mysteries of the condition and develop better treatments. The largest charitable funder of Parkinson’s research in Europe, we’re … Type: | 1 | 0 | 0 | 586 |
 | Adjuvant Capital Adjuvant Capital is the leading investment fund focused on public health. Adjuvant Capital is a life sciences investment firm focused on global health. We make $10-$25 million investments in ambitious companies targeting opportunities in high burden and neglected disease. Type: | 1 | 0 | 1 | 16 |
 | International Union of Crystallography Advancing crystallography and structural science through primary research publication and extensive outreach activities The IUCr is an International Scientific Union. Its objectives are to promote international cooperation in crystallography and to contribute to all aspects of crystallography, to promote international publication of crystallographic research, to facilitate standardization of methods, units, nomenclatures and symbols, and to form a focus for the relations of crystallography to other sciences. Publishing, Crystallography, Open Access, Science, journals, online communities, and databases Type: | 12 | 0 | 11 | 27 |
 | GAE Conseil [Automatic translation follows] Expert in the prevention of addictive practices in professional environments: advice, awareness, training, etc. G.A.E Conseil, the leading player in the prevention of addictive practices at work. Founded in 2014, GAE Conseil is an independent consulting firm specializing in the prevention of addictive practices in professional environments (psychoactive products and behavioral addictions). Around the partners of the firm and the heads of the different centers of expertise (Audit and Consulting Center, Training Center, Assistance Center for employees in difficulty), the GAE Conseil teams support private and public companies of all sizes and of all types. sectors of … Type: | 44 | 0 | 43 | 36 |
 | Ulysse Communication [Automatic translation follows] Who better than former journalists to make your voice heard? Ulysse Communication, at the crossroads of press and communication. Specializing in press relations and financial communications, Ulysse Communication was created by former economic and financial journalists who themselves surrounded themselves with former journalists. The agency and the team are strongly marked by this DNA which translates into an intimate knowledge of the media, an ability to develop tailor-made messages and a good understanding of the economic and business world. Press relations, Financial communication, Finance, Listed company, IPO, Financial operations, Public relations, Corporate communication, Asset management, Real estate, … Type: | 41 | 0 | 40 | 14 |
 | AudioTelligence Disruptive hearing technology start-up (CLOSED) Situational hearing loss is a huge and growing problem worldwide, affecting over 80% of people over 40. Often called ‘The Cocktail Party Problem’, this means that sufferers can hear speech clearly in quiet rooms, but in noisy situations they find it hard to follow conversations. AudioTelligence’s aisoTM technology can supercharge hearing enhancement on your device. AisoTM goes a step further than other solutions which simply reduce background noise, by isolating and extracting the speech or sound that the user wants to hear from surrounding noise and unwanted sounds. With aisoTM, users can effectively regain their … Type: | 17 | 0 | 15 | 7 |
 | Harlay Avocats #tech#startups#corporate#IP/IT#social#employment#tax Harlay Avocats (anciennement Kahn & Associés) est un cabinet d’avocats indépendant qui occupe depuis plus de vingt ans une place privilégiée dans le domaine du conseil aux entreprises de croissance et aux investisseurs dans les secteurs des technologies, de l’Internet, de l’e-commerce, des télécommunications, des sciences de la vie et des énergies renouvelables. La très bonne connaissance de ces secteurs d’activité permet au Cabinet d’être régulièrement sélectionné par les acteurs clés de ces domaines pour les assister lors de leurs opérations en France et à l’international. Le Cabinet conseille également les entreprises d’industries plus traditionnelles : presse et media, … | 5 | 0 | 4 | 37 |
 | Protera Smarter proteins for a sustainable future. By 2050, the world's population will surpass 10 billion people. To feed the current population and future generations we need to address global food challenges, today. How can we solve this problem without overwhelming the planet? And how can we deliver higher quality, more nutritious food for everyone? With Protera’s Natural IntelligenceTM technology, we believe the future is already here. Protera’s technology uses predictive algorithms that calculate millions of amino acid combinations and simulate protein patterns in a matter of seconds. Our technology is based in Deep Learning and allows us to shine a … Type: | 3 | 0 | 3 | 41 |
 | Science Entrepreneur Club Building communities. Enabling innovation. Connecting the life science ecosystem. We’re a non-profit on a mission to build meaningful communities to enable innovation and connect the life science ecosystem. We're building communities for entrepreneurs building in bio, investors actively backing life science companies and academics looking to break into industry. The SEC is the home of the BioFounder Club, BioCapital Network and BioAcademic Hub. entrepreneurship, innovation, science, engineering, life science, biotech, startup, networking, technology, and health Type: | 10 | 0 | 11 | 25 |
 | GTM Forum Navigate the Go to market landscape GTM Forum is your premier analyst partner in go-to-market strategies, serving leading B2B companies worldwide. Our expertise across multiple sectors uniquely positions us to address your complex challenges effectively. With our broad knowledge base and global reach, we are dedicated to making a significant impact on both our clients and the community. We create a collaborative environment that boosts your team's capabilities and leadership, providing tailored support to tackle fundamental issues and offer practical solutions. Our mission is to empower your organization to drive and maintain progress in your strategic endeavors. Specializing in mid-market … Type: | 33 | 0 | 33 | 23 |
 | EnginZyme Developing technologies to meet the sustainability goals of the future Our ambition is to play a key role in tackling climate change, by enabling green chemistry for every industry. We do this by creating the most general and efficient technology platform for chemical production that the world has ever seen. That’s a big claim, but we can stand behind it. By bio-upgrading the chemical industry with our cell-free biomanufacturing platform, we can produce the products that modern society relies on in a truly sustainable way. The technology platform utilises nature’s catalysts, enzymes, by combining the power of biology with the … Type: | 2 | 0 | 2 | 59 |
 | Numbered We are a design and technology agency crafting beautiful digital experiences and products Contact@numbered.com Numbered is an awards winning creative agency working with fashion, tech & lifestyle brands. We collaborate closely with our clients to tell their stories, engaging audiences by building beautiful experiences & products. Based in Amsterdam & New-york. We strongly believe every brand and project is unique and should be tailor-made from industry leaders to early stage companies. We don’t do one size fits all. Collaborating with international brands, founders, start-ups, venture capitals, and more – producing, results-driven, unique products and experiences from conception to delivery. With … Type: | 3 | 0 | 3 | 37 |
 | Regeneration.VC Supercharging Consumer-Powered Climate Innovation Regeneration.VC is an early-stage venture fund Supercharging Consumer-Powered Climate Innovation driven by circular and regenerative principles. We invest in Consumer ClimateTech companies that generate outsized economic and environmental outcomes across three strategies: Design (AgTech & Aquaculture and Next-Gen Materials), Use (Apparel & Lifestyle and Food & Beverage brands), and Reuse (ReCommerce and Reverse Logistics system technologies). Have an innovation ready to supercharge? Submit here: https://form.fillout.com/t/dDYPidgNx4us Circular Economy, Sustainable Investing, Venture Capital, Consumer, Climate Tech, Regeneration, and Consumer ClimateTech Type: | 38 | 0 | 38 | 21 |
 | Phytolon Natural Food Colors Phytolon offers natural food colors, uniquely positioned to comply with the consumers needs for healthy food, and with the industry requirements for cost-efficiency and high quality. Phytolon leverages a novel and sustainable fermentation-based technology by which betalain natural colors are produced in baker's yeast. food colors, natural ingredients, yeast, fermentation, sustainability, biotechnology, and foodtech Type: | 2 | 0 | 2 | 27 |
 | Abzena Abzena is the leading end-to-end bioconjugate & complex biologics CDMO+CRO, focused on rapidly moving medicines forward. Abzena is the leading end-to-end bioconjugate and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development of new treatments for patients in need. With the ability to tailor its strategy and customer experience to each project, Abzena develops and implements innovative solutions that enable biotech and biopharma companies to realize the full potential of their molecule and move medicines forward faster. The company has research, development, … Type: | 6 | 0 | 0 | 446 |
 | Virtonomy.io Accelerate and de-risk medical device development with digital patient twins and simulation Virtonomy introduces v-Patients, enabling medical device developers to perform development and testing in a virtual environment, thereby accelerating development, reducing risks, expenses, and regulatory burden. Our end-to-end digital twin and simulation solution is based on an ever-expanding database of real clinical data to reflect anatomical variability, demographic diversity and pathological conditions. digital health, virtual patients, digital twins, clinical trials, simulation, machine learning, AI, SaaS, simulated trials, cardiac database, and medtech Type: | 4 | 0 | 4 | 26 |
 | Algorithmiq We develop advanced quantum algorithms to solve complex problems in life sciences Algorithmiq is a company developing advanced algorithms to solve complex problems in life sciences. Our mission is to revolutionise life sciences by exploiting the potential of quantum computing to solve currently inaccessible problems. We combine our expertise in quantum information, complex systems, and computational physics to develop algorithms that run on near-term quantum devices to discover new drugs and develop new materials Quantum physics, Complex networks, Quantum computing, Quantum simulations, Quantum chemistry, Quantum software, and Computational physics Type: | 7 | 0 | 7 | 37 |
 | AstronauTx AstronauTx is tackling dementia through improving brain physiology AstronauTx is at the forefront of a novel approach to treating neurodegenerative diseases. We have a unique portfolio of small-molecule therapeutics to restore dysregulated physiology to both improve symptoms and modify disease. Type: | 2 | 0 | 1 | 11 |
 | ImmuONE Specialised translational approaches and in vitro testing services ImmuONE specialises in human alveolar macrophage responses, epithelial cell culture platforms and testing services. Our respiratory tissue models closely resemble lung physiology to provide relevant, reliable, and reproducible results. ImmuONE is partnered with the industry and academia to develop sustainable technologies for the future to support human-relevant, mechanistic driven safety assessments and develop animal product-free cell models. We offer a range of standard and bespoke assessments for inhalation safety assessment needs. ImmuONE provides innovative solutions for inhalation toxicology, irritation sensitization, alveolar clearance, inflammation and can tailor to your inhalation safety assessment needs. … Type: | 4 | 0 | 2 | 17 |
 | Qorium Real Leather, Reinvented Leather is loved. Leather is luxury. Leather is everywhere. Unfortunately, making leather is also polluting, challenging and controversial. Qorium creates beautiful, premium, and authentic leather without compromise. Cutting-edge science empowers us to dramatically reduce the vast impacts of today’s leather industry without quality reductions. By removing the cow from leather production, Qorium’s material has minimal climate impacts, low water and chemical usage, no land use, and no animal impacts. Simply put, Qorium reinvents leather. Better product. Better planet. Biotechnology, Cell cultured leather, Leather, Cell grown Leather, Sustainable Leather, and Animal free Leather Type: | 1 | 0 | 1 | 16 |
 | Mainstay Medical First and Only FDA Approved Restorative Therapy for Chronic Mechanical Low Back Pain Mainstay Medical, led by a team of dedicated scientists, executives, engineers, and clinical experts, brings to you ReActiv8®, the first and only FDA-approved restorative treatment for mechanical chronic low back pain. RESTORE Control RESTORE Function RESTORE Stability ReActiv8 LIFE The Company was incorporated in Dublin, Ireland and headquartered in San Diego, CA. It has subsidiaries operating in Ireland, the United States, Australia, Germany and the Netherlands. Type: | 1 | 0 | 1 | 126 |
 | Mauna Kea Technologies The real-time in vivo cellular imaging platform that revolutionizes the way physicians diagnose and treat patients. Mauna Kea Technologies is a global medical device company that manufactures and sells Cellvizio®, the real-time in vivo cellular imaging platform. This technology uniquely delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time, assess point-in-time reactions as they happen in real-time, classify indeterminate areas of concern, and guide surgical interventions. The Cellvizio platform is used globally across a wide range of medical specialties and is revolutionizing the way physicians diagnose and treat patients — making a transformative … Type: | 3 | 1 | 2 | 121 |
 | Talas Partners [Automatic translation follows] The right financing at the right time! Talas Partners is your partner of excellence to propel your company's innovation towards new horizons. Who are we ? Much more than a simple innovation financing consultancy firm, we become your partner to achieve your entrepreneurial objectives and lead you towards success. Our passion is to transform each innovative project into a successful entrepreneurial success. Our mission We have a clear mission: to help Startups and SMEs develop their businesses by mobilizing public or private financing. Our Support Present in the innovation ecosystem for a very long time, we guide … Type: | 4 | 1 | 3 | 3 |
 | Evaluate Ltd Evaluate provides trusted commercial intelligence and predictive analytics to the pharmaceutical industry Evaluate provides trusted commercial intelligence and predictive analytics for the pharmaceutical industry. We help our clients to refine and transform their understanding of the past, present and future of the global pharmaceutical market to drive better decisions. Evaluate solutions give you the time and confidence to turn understanding into insight, and insight into action: Evaluate Omnium - provides a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, delivering game-changing insight into pharma asset potential. EvaluatePharma - the trusted global view of the … Type: | 7 | 1 | 5 | 200 |
 | BIOTECanada Solving for today. Building for tomorrow. BIOTECanada serves as the national voice for Canada’s biotechnology sector. BIOTECanada is the national industry-funded association with over 250 member companies representing the broad spectrum of biotech constituents including emerging and established firms in the health, industrial, and agricultural sectors, as well as academic and research institutions and other related organizations. Through our national network of partner organisations, we inspire our domestic and international community to recognize the value of biotechnology and to provide solutions to the challenges faced by biotech firms today. Visit us at www.biotech.ca, and discover Canada's Biotechnology and Lifesciences Community … | 6 | 1 | 5 | 25 |
 | Pyrowave Electrifying progress. We are leading the revolution in #sustainable #greenchemistry by offering a modular microwave based technology that can #unzip waste plastics back to their root chemical form. Styrene, Polyolefin wax, Lubricants, Microwave, Plastics, #CircularEconomy, #LowCarbonCement , CleanTechnology, #Nanorecycling, GreenSolutions, and #WasteReduction Type: | 5 | 1 | 4 | 15 |
 | BRAIN Biotech AG Developing a biobased future is our passion. Industrial biotechnology is our business. BRAIN Biotech AG is a leading European supplier of biobased products and solutions such as enzymes and proteins, microbial production strains, natural compounds and biotechnological solutions for more sustainable industrial processes. We focus on the fields of nutrition, health and environment. BRAIN Biotech AG is the parent company of the international BRAIN Biotech Group. The Group's business activities are divided into the segments BioProducts, BioScience and BioIncubator. The BioProducts segment comprises the product business with specialty enzymes and other proteins, for which the Group operates fermentation facilities in … Type: | 3 | 1 | 1 | 186 |
 | NatureWorks A naturally advanced biomaterials company using plants to turn greenhouse gases into IngeoTM️ PLA biopolymers. NatureWorks is an advanced materials company offering a broad portfolio of renewably-sourced polymers and chemicals to the packaging, polymers, fibers, and chemicals markets. With performance and economics that compete with oil-based plastics and fibers, naturally advanced IngeoTM polymers are valued for their unique functional properties and used in products from coffee capsules and electronics to diapers and wipes. Creating performance through chemistry, VercetTM lactide-based solutions help innovators realize significant, measurable performance and cost advantages in products such as C.A.S.E., toners, and surfactants. NatureWorks is jointly … Type: | 10 | 1 | 2 | 210 |
 | May Health We are bringing a modern approach to the treatment of PCOS with our investigational Ovarian Rebalancing Treatment. May Health, formerly AblaCare, is developing a modern approach to PCOS. Type: | 1 | 1 | 1 | 16 |
 | T. Rowe Price T. Rowe Price is a premiere global asset management organization, actively investing in opportunities to help people thrive in an evolving world. Headquartered in Baltimore, Maryland, we provide a broad range of investment solutions across equity, fixed income, and multi-asset capabilities for clients around the world—from individuals to advisors to institutions to retirement plan sponsors. Our active, independent investing approach has guided how we do business for more than 85 years. Our professionals have diverse perspectives, but are united behind a commitment to rigorous research. They collaborate to identify market risks and opportunities that can give clients sharper insights and … Type: | 1 | 1 | 0 | 8,681 |
 | The Michael J. Fox Foundation for Parkinson's Research Here. Until Parkinson's isn't. The Michael J. Fox Foundation for Parkinson's Research is dedicated to finding a cure for Parkinson's disease through an aggressively funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's today. Type: | 7 | 1 | 6 | 355 |
 | Longwood Fund Longwood creates and invests in science-based companies that develop novel solutions for important medical problems Longwood creates and invests in science-based companies that develop novel solutions for important medical problems. Healthcare and Biotech and entrepreneurialism Type: | 4 | 1 | 0 | 19 |
 | TAC ECONOMICS An independent European research group providing advisory services on international economic and financial issues TAC ECONOMICS is a French independent leading provider of economic and financial consulting services with a strong expertise on country risk based on AI and data-driven solutions. Our team of experienced economists and data scientists specializes in providing cutting-edge data, models, and analysis to help our clients detect major risks and evaluate investment opportunities. Our commitment to AI and data-driven solutions is rooted in our pioneering work in the early 1990s, where we developed artificial intelligence tools to predict financial crises in emerging economies and prevent … | 6 | 1 | 3 | 12 |
 | Kickston [Automatic translation follows] Fundraising I M&A Kickston is a merchant bank that supports entrepreneurs in their fundraising and M&A operations. Industries: Consumer & B2B Tech • Fundraising: 2 to 10M€ • Transfer: Operations up to €15M Are you interested in our approach? Contact us! contact@kickston.co Type: | 27 | 1 | 27 | 9 |
 | Moorfields Eye Hospital, London Moorfields is one of the world’s leading eye hospitals, providing expertise in clinical care, research and teaching and education. Our main focus is the treatment and care of NHS patients with a wide range of eye problems, from common complaints to rare conditions, which require treatments not available anywhere else in the UK. We have over 30 locations in and around London, which enables us to provide expert treatment closer to patients’ homes. We are also a postgraduate teaching centre and a national centre for ophthalmic research involving, with the UCL Institute of Ophthalmology, the largest ophthalmic research programme in … Type: | 2 | 1 | 1 | 1,682 |
 | SafeHeal Reshaping RecoveryTM Established in 2015 and based in France, SafeHealTM is a clinical stage medical device manufacturer. Specializing in the development of anastomosis protection devices for colorectal surgery, SafeHeal’s premier device, Colovac, was invented by French surgeon Charam Khosrovani to eliminate the need for diverting ostomies in patients undergoing colectomy. medical device Type: | 2 | 1 | 0 | 18 |
 | Inventiva Pharma A clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies. Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical need in the areas of fibrosis, lysosomal storage disorders and oncology. Our research and development programs target indications with substantial unmet medical needs: NASH, MPS and oncology. Drug Discovery, Biotech, Oncology, Fibrosis, Lysosomal Storage Disorders, NASH, and SSc Type: | 1 | 1 | 0 | 117 |
 | Voisin Consulting Life Sciences (VCLS) Global reference partner to expedite access of HealthTech products to regulated markets. From discovery to product launch and lifecycle management At VCLS (Voisin Consulting Life Sciences), regulatory science guides Biotechnology, Pharmaceutical and Medtech manufacturers throughout product development and commercialization. Starting early in the process, from discovery to the patient, VCLS assists innovators in designing optimized product development plans and regulatory strategies, combining the health ecosystem with commercial success. With a presence in seven locations across three continents and over 200 employees, VCLS serves a broad range of healthtech developers and their investors. Together, we accompany global stakeholders to expedite HealthTech … Type: | 7 | 1 | 5 | 235 |
 | LimFlow SA Providing minimally-invasive options for the treatment of end-stage chronic limb-threatening ischemia (CLTI) LimFlow SA, part of Inari Medical, Inc., is a leading provider of medical technology that provides new hope to patients suffering from the most severe form of peripheral artery disease, Chronic Limb-Threatening Ischemia (CLTI), and who are facing the prospect of amputation. LimFlow is revolutionizing healthcare by offering a breakthrough solution for end-stage CLTI patients when traditional treatments fall short. Using an innovative percutaneous procedure, the LimFlow System reinvents anatomy to restore blood flow to the ischemic foot, which aims to alleviate pain, foster wound healing, reduce amputations … Type: | 1 | 1 | 0 | 39 |
 | SV Health Investors Investing in tomorrow's healthcare breakthroughs SV Health Investors is a specialist healthcare fund manager, investing across stages, geographic regions, and sectors, with expertise spanning biotechnology, dementia, healthcare growth, healthcare technology. Alongside our core funds, SV manages the Dementia Discovery Fund, focused on discovering and developing novel therapeutics for dementia. Venture Capital, Biotechnology, Medical Devices, Healthcare services, Private Equity, and Dementia Type: | 9 | 1 | 9 | 101 |
 | ICREA - Institució Catalana de Recerca i Estudis Avançats The need to know ICREA, Catalan Institution for Research and Advanced Studies, is a foundation supported by the Catalan Government and guided by a Board of Trustees. ICREA was created in response to the need to seek new hiring formulas that would make it possible to compete with other research systems on a similar footing by focusing on hiring only the most talented and extraordinary scientists and academics. ICREA is an institution without walls. It works hand in hand with Catalan universities and research centres to integrate ICREA research professors in the Catalan research system. ICREA offers permanent, tenured positions … Type: | 1 | 1 | 0 | 59 |
 | EryPharm EryPharm is a biotech start-up company dedicated to the development and the operation of a large-scale process for the production of Red Blood Cells from stem cells. The technology has been developed by Dr. Luc Douay and his team at the Paris Sorbonne university. You can contact EryPharm through our website: http://erypharm.com/contact.html Or you can contact Loïc Tron directly: www.linkedin.com/in/loictron Type: | 9 | 1 | 8 | 3 |
 | Myricx Bio Developing a new class of ADCs based on NMT inhibition to treat cancer We are a UK biotech company focused on the discovery and development of a completely novel class of selective cytotoxic payloads for antibody drug conjugates (ADCs), based on inhibitors of N-myristoyltransferases (NMT) for the treatment of cancer. Type: | 2 | 1 | 1 | 12 |
 | Bien Commun Advisory [Automatic translation follows] The conviction that, in the “common good”, the greatest good is first and foremost what is common to us. Bien Commun Advisory is a consulting firm in communications strategy, economic information, public affairs and media relations. Founded by Antoine Boulay in 2019, it now has around fifteen employees and operates for large companies, SMEs, start-ups, federations and players in the associative world. Type: | 34 | 1 | 29 | 14 |
 | World Bio Markets Driving the commercialisation of the Bioeconomy Join us 26th - 27th June 2024 for the next edition of World Bio Markets. Taking Place at The Hague in the Netherlands, World Bio Markets is the leading international business event connecting over 400 industry leaders with a packed programme of knowledge exchange, 1-2-1 meetings and networking. We bring together the right people, in the right environment in order to accelerate the transition to a fossil-free economy. "I've had two days of back to back meetings to discover companies and technologies that can help us achieve our 2030 sustainability goals. The event has … Type: | 29 | 1 | 27 | 16 |
 | Bruntwood 💡 Creating Thriving Cities: Workspace | Laboratories | Retail | Leisure Workspace | Laboratories | Retail | Leisure We own, let and manage outstanding buildings, workspace, innovation and science facilities through Bruntwood SciTech and Bruntwood Works. Our purpose: creating thriving cities. This purpose fuels our passion for supporting arts and culture, our deep community engagement and our ambitious plans for future growth. It ensures every investment and decision we make benefits our customers, our communities and our colleagues: because when our cities thrive, so do we. Our commitment to creating thriving cities has helped us to grow into a company … | 19 | 1 | 13 | 676 |
 | Tigem Telethon Institute of Genetics and Medicine TIGEM is a multidisciplinary research Institute devoted to the study of the mechanisms underlying rare genetic diseases and to the development of new therapies. The institute is one of the most important centers for fundamental life science research in Italy (https://www.tigem.it/). It is particularly renowned for its research on diseases such as lysosomal disorders, membrane trafficking defects, disorders of liver metabolism, and eye diseases. The unique funding environment of TIGEM forges important critical mass and facilitates opportunities to conduct both long-term and high-impact science that would otherwise be difficult to undertake. TIGEM is a … Type: | 1 | 1 | 1 | 299 |
 | Cyber Valley Europe’s largest AI research consortium Cyber Valley is Europe’s largest and leading research consortium in the field of artificial intelligence (AI) and modern robotics. Cyber Valley has a mission and a public mandate to advocate for entrepreneurship, research, development, application, and acceptance of technologies and methods in the field of intelligent systems. The company envisions a future where the full potential of intelligent systems is leveraged for the greater good of the world. The Cyber Valley Community connects partners from science, industry, and society, along with AI researchers and entrepreneurs. The Cyber Valley GmbH is funded by the state of … Type: | 9 | 1 | 6 | 20 |
 | Phacilitate Through conferences, community and market insights, we create partnerships that help advance the next pillar of medicine Phacilitate creates an environment where promising innovation can turn into the products that are changing the future of medicine. Recognised as the market leader in providing the life science sector with strategic insight, inspiration and unparalleled business networking, Phacilitate enables professionals to stay abreast of the issues driving life science innovation. #advancedtherapies #biotech #celltherapy #genetherapy Clinical Development, Cell Therapy, Gene Therapy, Oncology, Cancer, Precision Medicine, Biotech, Advanced Therapy, Biotechnology, and Life Sciences Type: | 4 | 1 | 3 | 18 |
 | Intermediate Capital Group (ICG) Global alternative asset manager, creating sustainable value by partnering with ambitious businesses. We are a global alternative asset manager with a track record of over 30 years. We are driven by purpose and sustainable results. We deliver outstanding investment performance to our clients, provide wide‐ranging capital solutions for corporates and owners of real assets, and create value for stakeholders, shareholders and communities. Private Markets, Private Capital, Alternative Asset Management, Private Credit, Private Debt, Secondaries, Structured Products, Real Assets, Infrastructure, Real Estate, and Life Sciences Type: | 6 | 1 | 2 | 739 |
 | Gradient Denervation Technologies Transforming the treatment of pulmonary hypertension A solution for patients suffering from heart failure with pulmonary hypertension. Type: | 1 | 1 | 0 | 13 |
 | Osage University Partners (OUP) Venture capital for university innovation. All sectors, all stages, all in. Osage University Partners (OUP) is a venture capital fund that invests exclusively in startups that are commercializing university research. OUP firmly believes that universities provide an unparalleled innovation engine and we have partnered with over 100 of the most entrepreneurial universities and research centers to invest in their startups. Profits are shared with affiliated institutions to further promote the university entrepreneurial ecosystem. Physical Sciences, Life Science, entrepreneurship, University Innovation, VC, Venture Capital, investing, startups, university startup, technology transfer, biotech, and science Type: | 5 | 1 | 4 | 20 |
 | Cancer Campus [Automatic translation follows] Cancer Campus is a research and innovation park developing in Villejuif (Val-de-Marne) Cancer Campus is a research and innovation park developing in Villejuif (Val-de-Marne), around Gustave Roussy, the first cancer center in Europe. Its objective is to bring together all the talents (health professionals, researchers, students, businesses) and citizens concerned by the disease to become an international reference site in innovation in health and oncology. In this context, we are developing 3 programs dedicated to promoting entrepreneurship in oncology: - the Oncoentrepreneur program: tailor-made training and support set up for start-up projects in biotech, medtech and e-health. … Type: | 5 | 1 | 3 | 3 |
 | Marks & Clerk Leading global network of intellectual property specialists We’re true specialists – focusing on IP and IP alone. With patent attorneys, trade mark attorneys, commercial lawyers and IP litigators, we can provide every type of intellectual property service you need. Our expertise is globally acknowledged - in our top tier status, the awards we’ve won and in the cutting-edge work we do, which helps shape future law. Intellectual property, Litigation, Prosecution, Patents, Trade Marks, and Law | 3 | 1 | 1 | 587 |
 | Noema Pharma Developing therapies to restore functioning in patients with orphan conditions of the brain and nervous system. Noema Pharma is a biotech company developing groundbreaking therapies to address the most disabling symptoms in orphan conditions of the brain and nervous system. Noema’s research and development is focused on understanding and meeting patient needs using our novel therapies. CNS | 1 | 1 | 0 | 32 |
 | Nuage Therapeutics We develop new selective and potent drugs for intrinsically disordered targets. Nuage Therapeutics is a spin-off from the Institute for Research in Biomedicine (IRB Barcelona) and ICREA. Nuage Therapeutics mission is to leverage biomolecular condensation and chemical biology to develop selective inhibitors of intrinsically disordered proteins involved in challenging indications representing unmet medical needs. Type: | 4 | 1 | 2 | 21 |
 | Life Extension The Science of a Healthier LifeTM Life Extension® is the health solutions expert that is translating scientific research into everyday insights for people wanting to live their healthiest lives. For almost 40 years, Life Extension® has pursued innovative advances in health, conducting rigorous clinical trials and setting some of the most demanding standards in the industry to offer a full range of quality vitamins and nutritional supplements and blood-testing services. Life Extension’s Wellness Specialists provide personalized counsel to help customers choose the right products for optimal health, nutrition and personal care. Type: | 1 | 1 | 0 | 442 |
 | LSI Moving Medtech forward, together 🟦 Join us at LSI USA '24 on March 18-22, 2024 LSI’s ecosystem provides the intelligence and relationships Medtech leaders need to build breakthrough businesses. We support thousands of innovators, investors, and strategics around the world working to move Medtech forward, together. For nearly two decades, our market intelligence solutions have powered strategic decisions for the world’s most successful Medtech, Life Science, and Healthcare organizations. With that foundation, we launched the LSI Emerging Medtech Summits with one vision: create forums for the leaders building, financing, and scaling Medtech innovation to challenge convention and catalyze better healthcare … Type: | 22 | 1 | 22 | 43 |
 | Kymab Ltd Kymab, a Sanofi company, based in Cambridge UK, is working to provide novel solutions in drug and vaccine development. Kymab, a Sanofi company, is a clinical-stage global biopharmaceutical company focused on the discovery and development of fully human monoclonal antibody drugs using its proprietary antibody platform which contains a full diversity of human antibodies, making it the most comprehensive antibody development platform available. Kymab’s platform has been designed to maximise the diversity of human antibodies produced in response to immunisation with antigens. Selecting from a broad diversity of fully human antibodies assures the highest probability of finding drug candidates with … Type: | 1 | 1 | 0 | 49 |
 | deepc Increasing diagnostic quality through the collaboration of medical professionals and AI. deepc is a pioneering company in the realm of Radiology AI, poised to democratize access to health at scale. At the heart of our mission is ourproduct deepcOS®, an unrivaled cloud-native Radiology AI platform. With a vendor-agnostic approach, deepcOS® boasts an expansive repository of cutting-edge AI applications. This groundbreaking platform empowers radiologists to seamlessly include AI insights into their clinical workflows, ushering in a new era of patient care excellence and elevated diagnostic precision. Visit our website now or simply email us at contact@deepc.ai Digital Health, Deep Learning, Machine … Type: | 1 | 1 | 0 | 74 |
 | Mosaic TX An oncology therapeutics company dedicated to resolving cancer’s complexity to power new treatments for patients. ABOUT US Mosaic Therapeutics is an oncology therapeutics company using advanced computational methods and next-generation cancer models to discover and develop novel targeted therapies. The company’s main mission is to tackle cancers with substantial unmet need by reinventing the traditional approach to target and drug discovery. Born out of pioneering research at the Wellcome Sanger Institute in collaboration with the Netherlands Cancer Institute, and anchored around a proprietary platform that has seen 20 years of fine-tuning and development, Mosaic has active programmes across a variety … Type: | 2 | 1 | 1 | 31 |
 | MoonLake Immunotherapeutics (NASDAQ: MLTX) Creating next-level therapies for inflammatory skin and joint diseases with Nanobody® science MoonLake Immunotherapeutics AG is a clinical-stage biopharmaceutical company leveraging revolutionary Nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases. Immunotherapy, inflammatory skin & joint diseases, partnering, IL17A / F, #MLTX, #Nanobody, #HS, #PsA, and #IL17 | 2 | 1 | 1 | 60 |
 | Womed This is a women's world Womed is pioneering innovative, safe and effective treatments to free women from challenging uterine pathologies: infertility, uterine bleeding, endometriosis. Type: | 10 | 1 | 1 | 12 |
 | Pi-Cardia Pi-Cardia is a medical device start-up company developing a novel low profile catheter for the treatment of Aortic Stenosis. The company's proprietary technology is based on delivering mechanical impact for creating scoring lines in valve calcification, without injuring the surrounding soft tissue. This treatment, which only takes several seconds, is intended to increase the valve effective orifice area without the need to replace the valve. Medical Device, Aortic Stenosis, Precautions Catheter-System, and Cardiovascular Type: | 1 | 1 | 0 | 58 |
 | Cure51 From Cancer Survivors to new drugs The first worldwide clinical and molecular database of exceptional survivors leading the path to new therapies against cancer. Type: | 2 | 1 | 0 | 15 |
 | The Drawdown The essential resource for private equity operations The Drawdown provides vital insight and analysis for mid and back office private equity professionals, including COOs, CFOs and investor relations. Our publication addresses and explores new demands facing the industry, as well as wider issues, to improve the effectiveness of private equity, and to maintain the industry’s leading status by encouraging responsible, socially aware behaviours. The Drawdown produces monthly magazines, daily online content, regular newsletters and several events. Sign up at The-Drawdown.com Private equity, Media, Events, Analysis, and Insight Type: | 8 | 2 | 7 | 5 |
 | Medicines Discovery Catapult Reshaping drug discovery for patient benefit. Independent, not-for-profit national innovation centre for drug discovery. We collaborate with UK medicines discovery and diagnostics organisations, giving them access to industry-leading expertise, cutting-edge technology, and high-quality data. We accelerate their progress, precision drugs get to clinical trials more rapidly, and patients get life-improving medicines earlier than they otherwise would have. biotechnology, pharma, medicines discovery, biotech, informatics, pharmaceuticals, drug discovery, tissue samples, discovery science and technology, virtual research and development, mass spectrometry, complex cell models, clinical data, biomarkers, tissue imaging, drug delivery, target engagement, target validation, omics, and drug research Type: | 9 | 2 | 6 | 194 |
 | IRB Barcelona International research centre devoted to offer biomedical solutions for #cancer and other diseases linked to #aging. IRB Barcelona’s research purpose is to address fundamental biological questions in order to provide groundbreaking solutions to unmet medical needs. Our institute is organised around three major research challenges: Cancer Science, Aging and Metabolism, and Mechanisms of Disease, with the aim to decipher why diseases develop and find new ways to diagnose, prevent and treat them. Approximately 400 scientists, technical and administrative staff from 29 countries currently work at IRB Barcelona. IRB Barcelona's ultimate objective is to translate research results to the clinic and … Type: | 3 | 2 | 2 | 466 |
 | United Ventures We support visionary entrepreneurs to reinvent industries through technology. At United Ventures we look for daring entrepreneurs willing to develop innovative products and technologies, who acknowledge the challenges and risks of our times and still crave to come out on top in business. As entrepreneurs ourselves, our mission is to spot winners and drive them to achieve success and worldwide recognition through our mentorship, financial and business development support. With a long-standing track record of both start-up and scale-up technological companies, we can boast the industry expertise, mentorship and business networking that it takes to create a success story. Thanks … Type: | 16 | 2 | 10 | 48 |
 | Casdin Capital, LLC Life Science Investments Casdin Capital, LLC is a New York-based research investment firm focused on the innovations in molecular medicine currently reshaping Life Sciences and healthcare. Founded in 2011, and with an eye to long-term returns and disruptive technologies, Casdin Capital is an expert working with experts, benefiting from its position at the crossroads of the science and investment communities. As trusted investor-partners in both private and public companies, we collaborate with industry leaders to fuel their visions, adding energy, insight, and experience to our over $2.4 billion under management. As we push into new markets and new developments, we … Type: | 6 | 2 | 0 | 48 |
 | American Chemical Society Improving all people’s lives through the transforming power of chemistry. The American Chemical Society is a congressionally chartered independent membership organization that represents professionals at all degree levels and in all fields of the chemical sciences. With more than 150,000 members, ACS is the world’s largest scientific society and one of the world’s leading sources of authoritative scientific information. A nonprofit organization, ACS is at the forefront of the evolving chemistry enterprise and the premier professional home for chemists, chemical engineers and related professions around the globe. ACS is dynamic and visionary, committed to “Improving all people’s lives through the … Type: | 3 | 2 | 0 | 2,192 |
 | Bicycle Therapeutics Bicycle Precision Guided Therapeutics. Bicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycles, for diseases that are underserved by existing therapeutics. Bicycles are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This constraint facilitates target binding with high affinity and selectivity, making Bicycles attractive candidates for drug development. Bicycle is evaluating BT5528, a second-generation Bicycle Toxin Conjugate (BTCTM) targeting EphA2; BT8009, a second-generation BTC targeting Nectin-4, a well-validated tumor antigen; and BT7480, a Bicycle TICATM targeting Nectin-4 and agonizing CD137, … Type: | 6 | 2 | 1 | 274 |
 | Novozymes Novozymes has combined with Chr. Hansen to become Novonesis: linkedin.com/company/novonesis. This global biosolutions company of 10,000 people is transforming how the world produces, consumes and lives. In 30-plus industries, its biosolutions help businesses meet their needs and the needs of our planet. Novozymes was formed in 2000 when Novo Nordisk split into three companies: Novo Nordisk A/S, Novozymes A/S and Novo A/S. Novozymes was the world leader in biological solutions with a commitment to Rethink Tomorrow. It served 130 markets with enzymatic, microbial and advanced protein solutions. The company’s solutions enabled higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel … Type: | 12 | 2 | 11 | 4,489 |
 | Crescendo Biologics Limited Crescendo Biologics - The T cell Enhancing Company Crescendo Biologics is a private, clinical stage immuno-oncology company developing novel, targeted T cell enhancing Humabody® therapeutics. Leading its proprietary pipeline, Crescendo Biologics has developed CB307, a novel half-life extended CD137 x PSMA Humabody for the selective activation of tumour-specific T cells exclusively within the tumour microenvironment. CB307 is designed to achieve a longer lasting anti-cancer effect whilst avoiding systemic toxicity, and the clinical programme for CB307 is underway in patients with PSMA positive solid tumours (NCT04839991). CB693 is a half-life extended CD137 x MSLN Humabody and is the second proprietary clinical … Type: | 4 | 2 | 3 | 63 |
 | Shockwave Medical Making waves for underserved patients with cardiovascular disease via novel technologies. ⚡🌊 Shockwave Medical is revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque. Inspired by 30-years of safety and efficacy in kidney stone treatment, our Intravascular Lithotripsy family of catheters delivers localized lithotripsy at the site of cardiovascular calcium that enables gentle balloon dilatation of calcified, stenotic arteries. IVL catheters use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed. An integrated balloon catheter then dilates the calcified lesion at low-pressure, restoring blood flow. Stay connected with … Type: | 2 | 2 | 1 | 1,123 |
 | Stifel Type: | 12 | 2 | 6 | 6,009 |
 | F-Prime Capital We create and invest in healthcare and technology companies that impact lives all over the world. Our roots are in one of America’s great entrepreneurial success stories. Fidelity Investments was founded in 1946 and grew from a single mutual fund into one of the largest asset management firms in the world, with over $2 trillion in assets under management. For the last forty years, our venture capital group has had the privilege of backing other great entrepreneurs as they built ground-breaking companies in technology and life sciences, including Atari, MCI, ROLM Corp., Alibaba, Ironwood Pharmaceuticals, and Ultragenyx. Today our funds … Type: | 7 | 2 | 6 | 81 |
 | Atlas Venture We build breakthrough biotech companies with remarkable life science entrepreneurs. Atlas Venture is a leading biotech venture capital firm. With the goal of doing well by doing good, we have been building breakthrough biotech startups since 1993. We work side by side with exceptional scientists and entrepreneurs to translate high impact science into medicines for patients. Our seed-led venture creation strategy rigorously selects and focuses investment on the most compelling opportunities to build scalable businesses and realize value. Biotech and Venture Capital Type: | 5 | 2 | 3 | 132 |
 | Motive Partners Investors, Operators, Innovators Motive Partners is a private equity firm with offices in New York City and London, focusing on growth equity and buyout investments in software and information services companies based in North America and Europe and serving five primary subsectors: Banking & Payments, Capital Markets, Data & Analytics, Investment Management and Insurance. Motive Partners brings differentiated expertise, connectivity and capabilities to create long-term value in financial technology companies. More information on Motive Partners can be found at www.motivepartners.com Type: | 11 | 2 | 4 | 117 |
 | Thuja Capital Healthcare Investors Thuja Capital is an early-stage venture capital firm located in Utrecht, The Netherlands. We invest in product focused companies that aim to have true impact for patients and doctors alike, as demonstrated in clinical studies to enable a health claim. Hence most of our ventures are active in the field of therapeutics, medical devices and digital health. Not only do we invest, we also take an active role in helping the company to become successful, by leveraging our extensive network and by bringing our own experience to the table. red biotechnology, life sciences, medical technology, diagnostics, medical devices, … Type: | 6 | 2 | 5 | 19 |
 | Chausson Partners We match smart money with great companies Chausson Finance is a leading fundraising advisory firm, providing deal making and equity story advice, as well as devoted support to inspiring founders. We helped shape +250 deals, and raise $1Bn. Our community of clients include leadership teams funded by Accel, Balderton, Alven and other top venture investors. Fundraising, Corporate Finance, Venture Capital, investment banking, equity rounds, M&A, Series A, Series B, and Equity Financing Type: | 18 | 2 | 16 | 17 |
 | Jefferies Jefferies, the global investment banking firm serving clients for 60 years. Jefferies is a leading global, full-service investment banking and capital markets firm that provides advisory, sales and trading, research and wealth and asset management services. With more than 40 offices around the world, we offer insights and expertise to investors, companies and governments. More about our company can be found at www.jefferies.com. Investment Banking, Fixed Income, Equities, Research & Strategy, Wealth Management, and Financial Services Type: | 7 | 2 | 5 | 7,428 |
 | Mission Therapeutics Mission Therapeutics is a private, drug discovery and development company focused on selectively targeting deubiquitylating enzymes to treat diseases of high unmet need. Mission has built a world-leading platform for the discovery and development of first-in-class, small-molecule drugs that selectively target deubiquitylating enzymes (DUBs) – an emerging, and hitherto intractable, drug class that is attracting significant commercial interest as the potential ‘Next Kinase Area’. Mission’s DUB platform is yielding a rich pipeline of novel therapeutics for the benefit of patients across therapeutic areas. Mission’s strategy is to create value by advancing its pipeline programmes through early clinical development, and preferentially … Type: | 6 | 2 | 5 | 37 |
 | 4BIO Capital London-based venture fund investing in advanced therapies 4BIO Capital is an international venture capital firm focused solely on the advanced therapies sector. 4BIO’s objective is to invest in, support, and grow early stage companies developing treatments in areas of high unmet medical need, with the ultimate goal of ensuring access to these potentially curative therapies for all patients. Specifically, it looks for viable, high-quality opportunities in cell and gene therapy, RNA-based therapy, targeted therapies, and the microbiome. The 4BIO team comprises leading advanced therapy scientists and experienced life science investors who have collectively published over 250 scientific articles in prestigious … Type: | 6 | 2 | 4 | 17 |
 | ARCH Venture Partners We are contrarian. We are bold. We are imaginative risk takers. Early stage venture firm focused on life science discoveries to prevent, detect and cure disease. Type: | 2 | 2 | 0 | 62 |
 | Inspirna, Inc. Converting cancer to a manageable, chronic condition Inspirna, Inc., is a privately-held clinical-stage biopharmaceutical company focused on the discovery and development of novel cancer drugs that target key pathways in cancers of high unmet need. Inspirna’s lead drug candidate, ompenaclid (RGX-202), is an orally-administered small molecule that targets the CKB/SLC6A8 pathway, which when activated enables the generation of ATP in response to tumor hypoxia. Ompenaclid is currently being tested in multiple mid-stage clinical trials in patients with advanced or metastatic RAS mutant colorectal cancer. Inspirna’s second clinical stage drug candidate, abequolixron (RGX-104), is an oral small molecule activator of LXR/APOE … Type: | 2 | 2 | 0 | 33 |
 | RefleXion Medical SCINTIX biology-guided radiotherapy is now FDA cleared. SCINTIX biology-guided radiotherapy now FDA cleared. SCINTIX® therapy detects and responds to signals emitted from the cancer itself and, for the first time, uses them to deliver immediate treatment for tumors in the lung or bone that may arise from primary or metastatic disease. cancer care, radiation therapy, life sciences, medical devices, biotechnology, oncology, manufacturing, PET scanner, electrical engineering, product engineering, algorithms engineer, new product development, and software engineering Type: | 2 | 2 | 1 | 240 |
 | Calliditas Therapeutics Pioneering treatments for rare diseases. We harness scientific & commercial expertise to improve the lives of patients. Calliditas is a specialty pharmaceutical company developing high value products for patients with significant unmet medical needs. With a highly experienced, dynamic management team, Calliditas draws on its extensive experience of pharmaceutical development and marketing to efficiently identify and progress valuable and de-risked products. Type: | 5 | 2 | 0 | 228 |
 | Panakes Partners Life Sciences dedicated VC firm Panakès Partners is a Venture Capital firm, based in Milan, which invests in the most ambitious companies and teams, developing revolutionary technologies and products, in the field of life sciences, aiming to improve the lives of people around the world, in two funds. Panakès, founded in 2015 by Fabrizio Landi, Alessio Beverina and Diana Saraceni, has 250 million under management. Panakes brings strong entrepreneurial and financial expertise to portfolio companies well beyond just capital, relying on a wide network of clinicians and industry experts. We have established relationships with selected industrial partners to assist our … Type: | 12 | 2 | 7 | 18 |
 | Varenne Capital Partners Varenne Capital Partners is a Paris-based, process-driven, global investment manager whose purpose is to deliver superior long-term returns with the minimum necessary risk-taking. We strive to achieve this goal by employing proprietary research and combining complementary investment frameworks in a single strategy: Long Equity, Short Equity, Merger Arbitrage and Tail Risk Hedging. Our ‘brokers are not welcome’ policy means that we rely exclusively on our own internal research and base our analysis on facts and figures. All of our investment frameworks stem from years of research and development and as a result comprise original methodologies, formalized processes, dedicated teams of … Type: | 5 | 2 | 1 | 38 |
 | LCA Studio Legale Your business partner LCA is an independent, full-service law firm, specialised in providing legal assistance to companies worldwide. Our offices are in Italy (Milan, Rome, Genoa, Treviso), Belgium (Brussels), and the United Arab Emirates (Dubai), where we operate in an International Partnership with IAA Middle East Legal Consultants LLP. LCA employs over 250 professionals specialised in all main areas of commercial, corporate, banking, finance, restructuring, tax, criminal, real estate, and labour law, and in all aspects of business law - including intellectual property, new technologies, transportation and insurance issues, art and food regulations - and in the protection of family … | 7 | 2 | 5 | 351 |
 | Mintz Built on excellence. Driven by change. Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo, P.C. is a general practice, full-service Am Law 100 law firm employing approximately 600+ attorneys serving clients worldwide. We are headquartered at One Financial Center in Boston’s Financial District and have additional US offices in Los Angeles, Miami, New York City, San Diego, San Francisco, Washington, DC, and an office in Toronto, Canada. Mintz was founded in 1933 by Haskell Cohn and Benjamin Levin. The firm’s Managing Member is Robert I. Bodian. Our collaborative attorneys work within four core practice areas — Transactional, Intellectual Property, Litigation & … Type: | 8 | 2 | 3 | 1,328 |
 | Redmile Group Redmile Group is a company based out of San Francisco. Type: | 2 | 2 | 0 | 55 |
 | baby vc Come for a VC bootcamp, stay for the community. First bootcamp for those who aspire to join the venture capital community. A unique program during which a group of aspiring VCs meet those who make venture capital. They reveal to us behind the scenes, the secrets and the future of their profession. Have a look at our job board juste here: [https://airtable.com/shrePuJCHfJbTq17m/tblsaFTVJnUA2JWuY] Are you a venture capital fund or startup looking for a stellar addition to your team? Then add your job offer via this form [https://airtable.com/shrYcgd6zU6VAKlRL] to get access to our fellows and our community 🤓 venture capital, bootcamp, … Type: | 61 | 2 | 59 | 200 |
Startup